By Cara Salvatore ( May 17, 2016, 5:16 PM EDT) -- The Second Circuit will not revive a former Pfizer medical director's claims that the company helped defraud the federal government after marketing cholesterol drug Lipitor off-label, saying that prescribing guidelines on a mid-2000s version of the label were not legal restrictions....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.